학술논문
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial
Document Type
Article
Author
Manno, D.; Bangura, A.; Baiden, F.; Ayieko, P.; Foster, J.; Connor, N.E.; Njie, Y.; Lawal, B.J.; Otieno, G.T.; Choi, E.M.-L.; Balami, A.D.; Adetola, H.H.; Lowe, B.; Greenwood, B.; Watson-Jones, D.; Kamara, A.B.; Kallon, J.; Conteh, M.; Koroma, B.; Borboh, P.; Kroma, M.T.; Deen, A.T.; Deen, G.F.; Samai, M.; Leigh, B.; Keshinro, B.; McLean, C.; Luhn, K.; Robinson, C.; Gaddah, A.
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, March 2023, 23(3):352-360)
Subject
Language
English
ISSN
14744457
14733099
14733099